Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Then maybe ADXS should have added in lieu of upfront cash we decided to negotiate terms at a later date with regards to revenue sharing if data progresses accordingly. This isn't a preclinical. Although many preclinicals are receiving upfront payments. The PR is vague at best
This deal appears to me there is no mega deal in the works. If they were close to deal with substantial upfront cash this wouldn't have happened.
I guess it will be used as leverage but I agree it seems we starting over with a new BP
We need high volume follow through today will be a great sign.
AlthoughADRO didn't move
That's what I think. Hoping it's more than that.
Looks like we leaking back down again. This is Frustrating
Their news is really good.
Didn't the EMA inspect and approve the facility as well... wouldn't that be connected to AXAL?
I hear that but I would think the price would move more
Catt. That's crazy. Do the MMs have that many shares in their coffers?
They indicated partnerships. Let's hope it's not just the existing ones. Time for Ranya to earn her cash
Warrant volume will be over 10k again today. Big increase someone sucking them up
Nice find.
They seem to tweet a lot. If that matters. This morning ADXS tweeted the summit photo at the White House with an article attached.
They vest over 3 years starting in November. So he wouldn't get them. Good try though
If it was options I would tend to agree but the RSU doesn't matter when granted because the cost is 0 to Dan and the No News crew. Plus the first third don't vest till Nov. so he couldn't sell them anyway if he wanted too. (Barring buyout).
I doubt that. The 3 year vest for the recent shares would vest but not the un-awarded shares
That is correct I copy the response I received:
JB,
I don't know how many were submitted. Remember that abstracts are due early in the year so in order to present at ASCO you need to have data in hand and ready to submit in January.
One abstract was accepted for online publication. We will have data updates later this year at other medical conferences.
Regards,
Ranya
They should update the presentation. Prelim her2 said by ASCO. Wasn't accepted. That's a shame
I just emailed Hans from IR and asked how many were submitted and how many were accepted. Keep you posted
Possible but I highly doubt or deal would've been announced or no later than tomorrow. I wouldn't pull abstracts until deal announced. IMO Just common business sense
My thought process if I didn't have a deal signed and sealed prior to submitting abstract deadline. I would've submitted the abstracts otherwise we'd be here so to speak with no deal announced and no abstracts at ASCO
I doubt it. The deal would've been announced prior to submission deadline.
Got it. I thought it was for the public today. Thanks
Anyone know when The ASCO selections come out today?
James,
Petit just tweeted this article. Seems like your ahead of ADXS. Lol
That is correct. There is a premium built in. The premium will decay as we get closer to expiration which is 10/18.
You seem to flip flop a lot per your past posts. Could it be you're trading?
Congrats James!!
Shub. Our lead candidate trials are pretty much all paid for. What r u talking about?
How ironic the price was suppressed the last couple days before what I think is significant news and a telltale sign of EU approval. Scum bag Wall Street
I'm thinking/hoping this shelf goes with a monster upfront payment from Astra or whomever. It's double the Amgen purchase so I would expect way more than 40 mill. Upfront due to the progress of AXAL being in phase 3.
FBG. Let's hope DOC overwhelms us with an AXAl deal shortly.
Is it possible that the 50 million dollar registration will be the equity purchase by astra.
Price is at 8.50 which I believe is the same price as Amgen bought their 25 million dollar purchase.
So hopefully their upfront is at least 100 million in addition to equity commitment - which would be more than double.
Lastly I hope this is only for EU.
Just a thought.
Shorts are not required to be disclosed. I doubt they're shorting but more likely lending their shares for interest.
Give it a rest
Don't forget yesterday was OPEX for march. That was probably the reason.
Yesterday's close.
That's what I thought too. It's probably like 30-35% retail